These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6104908

  • 21. Pergolide in late-stage Parkinson disease.
    Lang AE, Quinn N, Brincat S, Marsden CD, Parkes JD.
    Ann Neurol; 1982 Sep; 12(3):243-7. PubMed ID: 6753730
    [Abstract] [Full Text] [Related]

  • 22. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
    LeWitt PA, Gopinathan G, Ward CD, Sanes JN, Dambrosia JM, Durso R, Calne DB.
    Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
    Stern G, Lees A.
    Adv Neurol; 1987 Jan; 45():525-7. PubMed ID: 3103395
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Mental confusion during the treatment of Parkinson disease with trihexyphenidyl].
    Graux P, Durocher AM, Copin JM.
    Lille Med; 1980 Jan; 25(6):271-2. PubMed ID: 7401896
    [No Abstract] [Full Text] [Related]

  • 31. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM, Lees AJ, Shaw KM, Lander CM.
    Adv Biochem Psychopharmacol; 1980 Jan; 23():267-70. PubMed ID: 7395617
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
    Baas H, Schneider E, Fischer PA, Japp G.
    J Neural Transm; 1985 Jan; 64(1):45-54. PubMed ID: 4067602
    [Abstract] [Full Text] [Related]

  • 36. Bromocriptine in the treatment of parkinsonism.
    Parkes JD.
    Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Psychiatric manifestations induced by dopamine precursors or antagonists].
    Leger JM, Dumond JJ, Garoux R, Lombertie E, Dumas M.
    Ann Med Psychol (Paris); 1979 Nov; 137(9):899-908. PubMed ID: 398173
    [No Abstract] [Full Text] [Related]

  • 40. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Duvoisin RC, Heikkila RE, Manzino L.
    Neurology; 1982 Dec; 32(12):1387-91. PubMed ID: 6128698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.